Aurora Cannabis (ACB) News
Latest news and analysis
Aurora Cannabis Faces Fresh Scrutiny as Analysts Reassess Fundamentals
ACB stock draws renewed analyst attention amid shifting cannabis market dynamics and evolving investor expectations for profitability.
Aurora Cannabis Plunges 28%: Analyzing the Three-Month Selloff
ACB shares face mounting pressure as cannabis sector headwinds intensify. We examine whether the 28% decline creates opportunity or signals deeper troubles ahead.
Aurora Cannabis Leverages Medical Expansion to Drive International Revenue
ACB's strategic focus on global medical cannabis markets positions the company for sustainable growth amid challenging recreational headwinds.
Aurora Cannabis Stock Surges Following Record Annual Results
ACB shares climb as the Canadian cannabis producer reports its strongest annual performance, signaling potential turnaround for the struggling sector.
Aurora Cannabis Breaks Ground as First Cannabis Firm on TIME's Best List
ACB earns historic recognition on TIME Canada's Best Companies 2026, signaling potential shift in institutional perception of cannabis sector legitimacy.
Aurora Cannabis Lands TIME Canada Recognition Amid Operational Turnaround
ACB earns spot on TIME Canada's Best Companies 2026 list as the cannabis producer works to rebuild credibility following years of restructuring and cost-cutting.
Aurora Cannabis Files Proxy Materials for Annual Shareholder Meeting
ACB distributes management circular ahead of upcoming AGM, setting stage for key governance decisions and strategic direction votes.
Aurora Cannabis Hits Record EBITDA as European Strategy Pays Off
ACB posts strongest profitability metrics to date, driven by expanding European medical cannabis operations and improving operational efficiency across key markets.
Aurora Cannabis Pushes International Medical Expansion Strategy
Aurora Cannabis accelerates global medical cannabis footprint as company seeks revenue diversification beyond struggling domestic recreational market.
Aurora Cannabis Stock Surges on Renewed Institutional Interest
ACB shares climb as institutional investors reassess cannabis sector valuations amid improving fundamentals and regulatory tailwinds.
Aurora Cannabis Surges on Record EBITDA Performance
ACB shares climb as the Canadian cannabis producer delivers its strongest adjusted EBITDA results, signaling operational turnaround momentum.